Suppr超能文献

膀胱癌患者血清β2微球蛋白的测定(作者译)

[Estimation of serum beta 2 microglobulin in carcinoma of the bladder (author's transl)].

作者信息

Dimopoulos C, Fertakis A, Stathopoulos C, Goulandris N, Kastriotis J, Antipas A, Melissinos K

出版信息

J Urol (Paris). 1982;88(1):11-3.

PMID:6174647
Abstract

beta 2 Microglobulin is a low molecular weight protein synthesised by lymphocytes and neoplastic cells. The authors measured levels of this substance in the plasma of 40 patients with carcinoma of the bladder and normal renal function. 26 subjects were used as controls. Plasma levels were markedly higher in the bladder carcinoma sufferers than in the normal controls. Levels were also higher in invasive carcinomas than in superficial lesions. beta 2 microglobulin may therefore not be considered to be a specific indicator of carcinoma of the bladder but rather as a factor offering the possibility of measurement of the secretory activity of tumour cells.

摘要

β2微球蛋白是一种由淋巴细胞和肿瘤细胞合成的低分子量蛋白质。作者测定了40例膀胱肿瘤且肾功能正常患者血浆中该物质的水平。26名受试者作为对照。膀胱癌患者血浆水平明显高于正常对照组。浸润性癌患者的水平也高于浅表性病变患者。因此,β2微球蛋白可能不能被视为膀胱癌的特异性指标,而更应被看作是一种能够测量肿瘤细胞分泌活性的因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验